Reactosome
Synthetic cell platform
Reactosome is a company in therapeutics based in San Francisco Bay Area, West Coast, Western US, founded in 2023.
Profile
Reactosome is a synthetic cell platform that enables an efficient new class of nucleic acid therapies, unlocking treatments for complex diseases like solid cancers and age-related disorders by affecting 10x more genes than traditional methods
As a business in therapeutics, Reactosome is listed here with the public details available about it.
Its base of operations is San Francisco Bay Area, West Coast, Western US.
Its current recorded stage is Pre_Seed.
Its team size is recorded as 2-10 employees.
| Sector | Therapeutics |
|---|---|
| Headquarters | San Francisco Bay Area, West Coast, Western US |
| Country | Germany |
| Founded | 2023 |
| Employees | 2-10 |
| Stage | pre_seed |
Website: reactosome.com
Sign in to view the contact information we hold for Reactosome.
Create a free account
Create a free account